Merck files quarterly report (10-Q) for the period ended Sep 30, 2025

Merck filed its quarterly report on Form 10-Q with the SEC on Nov 5, 2025, 4:08 PM ET, covering the quarter ended Sep 30, 2025. It reports fiscal Q3 2025 results.

• Revenue: $17.28B (+3.7% from $16.66B a year earlier)
• Net income: $5.79B (+83.2% from $3.16B a year earlier)
• Diluted EPS: $2.32 (+87.1% from $1.24 a year earlier)
• Form 10-Q accepted by EDGAR Nov 5, 2025, 4:08 PM ET
• Accession number 0000310158-25-000059

SEC filing 10-Q · accession 0000310158-25-000059 · sec.gov ↗